Skip to main content

Solute carrier family 22 member 18 Antibody - BSA Free

Novus Biologicals, part of Bio-Techne | Catalog # NBP3-45334

Novus Biologicals, part of Bio-Techne

Key Product Details

Species Reactivity

Human, Mouse, Rat

Applications

ELISA, Immunoprecipitation, Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit IgG

Format

BSA Free

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

solute carrier family 22, member 18. (Uniprot# Q96BI1)

Clonality

Polyclonal

Host

Rabbit

Isotype

IgG

Scientific Data Images for Solute carrier family 22 member 18 Antibody - BSA Free

Solute carrier family 22 member 18 Antibody - BSA Free

Western Blot: Solute carrier family 22 member 18 Antibody - BSA Free [NBP3-45334] -

Western Blot: Solute carrier family 22 member 18 Antibody - BSA Free [NBP3-45334] - Mouse brain tissue were subjected to SDS PAGE followed by western blot with (Solute carrier family 22 member 18 antibody) at dilution of 1:1000
Solute carrier family 22 member 18 Antibody - BSA Free

Immunoprecipitation: Solute carrier family 22 member 18 Antibody - BSA Free [NBP3-45334] -

Immunoprecipitation: Solute carrier family 22 member 18 Antibody - BSA Free [NBP3-45334] - IP Result of anti-Solute carrier family 22 member 18 (IP:, 4ug; Detection: 1:600) with mouse brain tissue lysate 4000ug.

Applications for Solute carrier family 22 member 18 Antibody - BSA Free

Application
Recommended Usage

Immunoprecipitation

1:200-1:2000

Western Blot

1:500-1:2000
Application Notes
Theoretical Molecular Weight is 40-50 kDa

Formulation, Preparation, and Storage

Purification

Immunogen affinity purified

Formulation

PBS, 50% Glycerol, pH (7.3)

Format

BSA Free

Preservative

0.02% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at -20C. Avoid freeze-thaw cycles.

Background: Solute carrier family 22 member 18

Solute carrier family 22 member 18 is one of several tumor-suppressing subtransferable fragments located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer. This gene may play a role in malignancies and disease that involve this region as well as the transport of chloroquine- and quinidine-related compounds in the kidney. Two alternative transcripts encoding the same isoform have been described.

Alternate Names

BWR1AORCTL2, BWSCR1Asolute carrier family 22 (organic cation transporter), member 1-like, Efflux transporter-like protein, HET, imprinted multi-membrane spanning polyspecific transporter-related protein 1, Imprinted multi-membrane-spanning polyspecific transporter-related protein 1, IMPT1DKFZp667A184, ITMp45-BWR1A, ORCTL-2, organic cation transporter-like 2, Organic cation transporter-like protein 2, p45 Beckwith-Wiedemann region 1A, SLC22A1Lcandidate A, solute carrier family 22 member 18, Solute carrier family 22 member 1-like, solute carrier family 22, member 18, TSSC5p45-Beckwith-Wiedemann region 1 A, Tumor-suppressing STF cDNA 5 protein, Tumor-suppressing subchromosomal transferable fragment candidate gene 5 protein

Gene Symbol

SLC22A18

Additional Solute carrier family 22 member 18 Products

Product Documents for Solute carrier family 22 member 18 Antibody - BSA Free

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for Solute carrier family 22 member 18 Antibody - BSA Free

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...